During the past decade, UCLA Ataxia Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Ataxia Center" #1 collaborator was "Friedreich's Ataxia Research Alliance" with 1 trials as a collaborator, "Takeda" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Ataxia Center" are "Friedreich Ataxia" (2 trials) and "Neuro-Degenerative Disease" (1 trials). Many other conditions were trialed in "UCLA Ataxia Center" in a lesser frequency.

Most popular intervention types in "UCLA Ataxia Center" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "TAK-831" (1 trials) and "TAK-831 Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Ataxia Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Ataxia Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UCLA Ataxia Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Ataxia Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".